
Lotus Eye Hospital & Institute Ltd is Rated Strong Sell
2026-11-18 10:10:30Lotus Eye Hospital & Institute Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 18 November 2026, providing investors with the most recent insights into its performance and outlook.
Read More
Lotus Eye Hospital & Institute Ltd: Valuation Shifts Signal Elevated Price Risk
2026-11-18 08:05:39Lotus Eye Hospital & Institute Ltd has witnessed a significant shift in its valuation parameters, moving from an attractive to an expensive rating. Despite a modest day gain of 3.18%, the company’s price-to-earnings (P/E) ratio has surged to an eye-watering 487.21, raising questions about its price attractiveness relative to historical and peer benchmarks.
Read MoreLotus Eye Hospital Shares Slip 0.19% Amid Valuation Concerns and Margin Pressure
2026-11-14 14:01:40Key Events This Week Nov 09: Stock falls 4.12% to Rs.102.40 on weak sentiment Nov 11: Valuation concerns highlighted; stock rebounds 3.32% to Rs.105.80 Nov 12: Q2 FY27 results reveal margin pressure; stock dips 0.90% to Rs.104.85 Nov 13: Stock recovers 1.67% to close at Rs.106.60 despite Sensex decline Week OpenRs.106.80 We...
Read More
Lotus Eye Hospital & Institute Ltd is Rated Strong Sell
2026-11-01 10:10:19Lotus Eye Hospital & Institute Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 September 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 November 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read More
Lotus Eye Hospital & Institute Ltd Valuation Surges to Very Expensive Levels Amid Mixed Returns
2026-10-30 08:02:34Lotus Eye Hospital & Institute Ltd has seen a marked shift in its valuation parameters, moving from an already expensive rating to a very expensive classification. With a staggering price-to-earnings (P/E) ratio of 1416.75 and a price-to-book value (P/BV) of 3.77, the stock’s price attractiveness has significantly diminished relative to its historical averages and peer group, prompting a downgrade to a strong sell rating.
Read More
Lotus Eye Hospital & Institute Ltd: Valuation Shifts Signal Price Attractiveness Change
2026-10-23 08:02:23Lotus Eye Hospital & Institute Ltd has seen a notable shift in its valuation parameters, moving from a very expensive to an expensive rating, despite a modest day gain of 0.73%. This article analyses the implications of its elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to historical trends and peer benchmarks, providing a comprehensive view of its current market standing and investment appeal.
Read More
Lotus Eye Hospital & Institute Ltd is Rated Strong Sell
2026-10-21 10:10:19Lotus Eye Hospital & Institute Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 September 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 21 October 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Lotus Eye Hospital & Institute Ltd is Rated Strong Sell
2026-10-10 10:10:05Lotus Eye Hospital & Institute Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 17 September 2026, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed below represent the stock's current position as of 10 October 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Lotus Eye Hospital & Institute Ltd is Rated Strong Sell
2026-09-29 10:10:03Lotus Eye Hospital & Institute Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 17 September 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 29 September 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
20-Nov-2026 | Source : BSENewspaper Advertisements published for Notice of Postal Ballot
Initmation Of Transmission Of Shares
20-Nov-2026 | Source : BSETransmission of Shares of Deceased Promoter to Existing Promoters of the Company
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
19-Nov-2026 | Source : BSENotice of Postal Ballot
Corporate Actions
No Upcoming Board Meetings
Lotus Eye Hospital & Institute Ltd has declared 5% dividend, ex-date: 18 Sep 23
No Splits history available
No Bonus history available
No Rights history available